Chitosan 3D Sphere Mediated Promotion of Chondrogenesis in hMSC Depends on mTOR-S6K Pathway

Chitosan 3D Sphere Mediated Promotion of Chondrogenesis in hMSC Depends on mTOR-S6K Pathway

碩士 === 國立陽明大學 === 解剖學及細胞生物學研究所 === 104

Bibliographic Details
Main Authors:	Tsai-Jung Lu, 呂采蓉
Other Authors:	Ming-Chau Chang
Format:	Others
Language:	en_US
Published:	2016
Online Access:	http://ndltd.ncl.edu.tw/handle/50050454488994760426

Similar Items

hMSC response to augmented CaP nanotopography
by: McLister, Robert
Published: (2016)

Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice.
by: Silvia Mora-Lee, et al.
Published: (2012-01-01)

Comparison of Hyclone and Biow: Effect to hMSC Proliferation, Morphology, and Osteogenic Differentiationest
by: Tania Saskianti, et al.
Published: (2013-01-01)

Effect of industrial GMP human plasma derived supplement on hMSC behaviour
by: Maura Cimino
Published: (2020)

Regulation of endothelial cell arrangements within hMSC – HUVEC co-cultured aggregates
by: Anthony J. Deegan, et al.
Published: (2019-06-01)

Deletion of miR-675 in hMSC-TERTs leads to increased ALP activity
by: Ines Foessl, et al.
Published: (2020-10-01)

Theoretical and Practical Issues That Are Relevant When Scaling Up hMSC Microcarrier Production Processes
by: Valentin Jossen, et al.
Published: (2016-01-01)

To investigate the proliferation mechanism of hMSC by transducing Notch 1 intracellular domain-coupled magnetic nanoparticle
by: KUAN,YU-HSIN, et al.
Published: (2018)

Metabolism in Human Mesenchymal Stromal Cells: A Missing Link Between hMSC Biomanufacturing and Therapy?
by: Xuegang Yuan, et al.
Published: (2019-05-01)

Effect of Topography and Physical Stimulus on hMSC Phenotype Using a 3D In Vitro Model
by: Deepak Kumar, et al.
Published: (2019-04-01)

Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides
by: Stephan Altmann, et al.
Published: (2021-03-01)

mTOR signaling pathway and mTOR inhibitors in the treatment of cancer
by: Mehmet Küçüköner, et al.
Published: (2013-03-01)

PI3K/AKT/mTOR pathway in Angiogenesis
by: Jayashree eKarar, et al.
Published: (2011-12-01)

All PI3Kinase signaling is not mTOR: Dissecting mTOR-dependent and independent signaling pathways in T cells
by: Christopher Jordan Gamper, et al.
Published: (2012-10-01)

Human platelet lysate to substitute fetal bovine serum in hMSC expansion for translational applications: a systematic review
by: M. Guiotto, et al.
Published: (2020-09-01)

Principal Criteria for Evaluating the Quality, Safety and Efficacy of hMSC-Based Products in Clinical Practice: Current Approaches and Challenges
by: Juan Antonio Guadix, et al.
Published: (2019-10-01)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
by: Zhilin Zou, et al.
Published: (2020-03-01)

A Proteomic View to Characterize the Effect of Chitosan Nanoparticle to Hepatic Cells: Is Chitosan Nanoparticle an Enhancer of PI3K/AKT1/mTOR Pathway?
by: Ming-Hui Yang, et al.
Published: (2014-01-01)

mTOR Pathways in Cancer and Autophagy
by: Mathieu Paquette, et al.
Published: (2018-01-01)

TDRG1 functions in testicular seminoma are dependent on the PI3K/Akt/mTOR signaling pathway
by: Wang Y, et al.
Published: (2016-01-01)

AKTivation of the PI3K/AKT/mTOR signaling pathway by KSHV
by: Aadra P Bhatt, et al.
Published: (2013-01-01)

Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies
by: Sarah K Tasian, et al.
Published: (2014-05-01)

Evaluación comportamental del trasplante de hMSC-GFP+ en un modelo experimental de hemiparkinson en rata Wistar
by: Jéssica Paola Alcázar Arzuza, et al.
Published: (2017-05-01)

Rosmarinus Improved Skin Flap Survival Through mTOR Dependent Pathway
by: Javid Zeinab, et al.
Published: (2018-12-01)

The mTOR Signalling Pathway in Human Cancer
by: Paula Soares, et al.
Published: (2012-02-01)

Harnessing the mTOR Pathway for Tuberculosis Treatment
by: Pooja Singh, et al.
Published: (2018-01-01)

Targeting the mTOR pathway in breast cancer
by: Jia Liu, et al.
Published: (2017-06-01)

Células troncales mesenquimáticas humanas (hMSC) eliminan eficientemente las especies reactivas de oxígeno (ROS) y de nitrógeno (RNS)
by: Valle Prieto, María Araceli
Published: (2012)

mTOR-Dependent Cell Proliferation in the Brain
by: Larisa Ryskalin, et al.
Published: (2017-01-01)

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
by: Huayi Li, et al.
Published: (2021-07-01)

Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
by: R. Reilly, et al.
Published: (2017-08-01)

The PI3K/AKT/mTOR signaling pathway is overactivated in primary aldosteronism.
by: Hengchuan Su, et al.
Published: (2013-01-01)

PI3K/Akt/mTOR signaling pathway and malignant hepatobiliary tumors
by: CHEN Xuxiao
Published: (2015-06-01)

Targeting the PI3K/Akt/mTOR Signaling Pathway: Applications of Nanotechnology
by: Forough Alemi Serej, et al.
Published: (2018-01-01)

Role of PI3K/Akt/mTOR signaling pathway in hepatocellular carcinoma
by: YU Yuan
Published: (2014-09-01)

Targeting of the PI3K/AKT/mTOR pathway in human prostate cancer
by: Butler, Dominika Ewelina
Published: (2014)

Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
by: Geyer, Natalie
Published: (2018)

TGF-β1-induced chondrogenesis of bone marrow mesenchymal stem cells is promoted by low-intensity pulsed ultrasound through the integrin-mTOR signaling pathway
by: Peng Xia, et al.
Published: (2017-12-01)

Role of PI3K/mTOR/S6K1 signaling pathway in Diabetic Nephropathy
by: Chu-Yun Cheng, et al.
Published: (2011)

mTOR-Dependent and Independent Survival Signaling by PI3K in B Lymphocytes.
by: Mary Kaileh, et al.
Published: (2016-01-01)

Cannot write session to /tmp/vufind_sessions/sess_2njelv8cp25eed3ib92m31kptj